133 related articles for article (PubMed ID: 26313124)
1. The influence of asthma control on psychosocial outcomes for pregnant women with asthma.
Burgess L; McCaffery K; Powell H; Murphy VE; Gibson PG; Turner RM
J Asthma; 2015; 52(10):1013-9. PubMed ID: 26313124
[TBL] [Abstract][Full Text] [Related]
2. Rhinitis in pregnant women with asthma is associated with poorer asthma control and quality of life.
Powell H; Murphy VE; Hensley MJ; Giles W; Clifton VL; Gibson PG
J Asthma; 2015; 52(10):1023-30. PubMed ID: 26365758
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma.
Powell H; McCaffery K; Murphy VE; Hensley MJ; Clifton VL; Giles W; Gibson PG
J Asthma; 2011 Dec; 48(10):1032-40. PubMed ID: 22091740
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial variables are related to future exacerbation risk and perinatal outcomes in pregnant women with asthma.
Powell H; McCaffery K; Murphy VE; Hensley MJ; Clifton VL; Giles W; Gibson PG
J Asthma; 2013 May; 50(4):383-9. PubMed ID: 23368420
[TBL] [Abstract][Full Text] [Related]
5. Perceived control and quality of life in asthma: impact of asthma education.
Olajos-Clow J; Costello E; Lougheed MD
J Asthma; 2005 Nov; 42(9):751-6. PubMed ID: 16316869
[TBL] [Abstract][Full Text] [Related]
6. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial.
Powell H; Murphy VE; Taylor DR; Hensley MJ; McCaffery K; Giles W; Clifton VL; Gibson PG
Lancet; 2011 Sep; 378(9795):983-90. PubMed ID: 21907861
[TBL] [Abstract][Full Text] [Related]
7. [The long-term variability of FeNO in pregnant asthmatic women with controlled asthma].
Dor-Wojnarowska A; Nittner-Marszalska M; Liebhart J; Marszalska H; Pawłowicz R; Gillert M; Kazimierczak A; -Filarska MK; Panaszek B
Pneumonol Alergol Pol; 2013; 81(2):114-20. PubMed ID: 23420427
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial.
Syk J; Malinovschi A; Johansson G; Undén AL; Andreasson A; Lekander M; Alving K
J Allergy Clin Immunol Pract; 2013; 1(6):639-48.e1-8. PubMed ID: 24565712
[TBL] [Abstract][Full Text] [Related]
9. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both?
Lavoie KL; Bacon SL; Barone S; Cartier A; Ditto B; Labrecque M
Chest; 2006 Oct; 130(4):1039-47. PubMed ID: 17035436
[TBL] [Abstract][Full Text] [Related]
10. [Lack of correlation between exhaled nitric oxide (eNO) and clinical indicators of the disease activity and quality of life in mild and moderate asthmatics].
Tworek D; Bocheńska-Marciniak M; Kupczyk M; Kupryś-Lipińska I; Kuna P
Pneumonol Alergol Pol; 2006; 74(4):391-5. PubMed ID: 17427148
[TBL] [Abstract][Full Text] [Related]
11. Observational study of mental health in asthmatic women during the prenatal and postnatal periods.
Whalen OM; Campbell LE; Murphy VE; Lane AE; Gibson PG; Mattes J; Collison A; Mallise CA; Woolard A; Karayanidis F
J Asthma; 2020 Aug; 57(8):829-841. PubMed ID: 31148493
[No Abstract] [Full Text] [Related]
12. Asthma during pregnancy: the experiences, concerns and views of pregnant women with asthma.
Lim AS; Stewart K; Abramson MJ; Ryan K; George J
J Asthma; 2012 Jun; 49(5):474-9. PubMed ID: 22530982
[TBL] [Abstract][Full Text] [Related]
13. Clinical control of asthma associates with measures of airway inflammation.
Volbeda F; Broekema M; Lodewijk ME; Hylkema MN; Reddel HK; Timens W; Postma DS; ten Hacken NH
Thorax; 2013 Jan; 68(1):19-24. PubMed ID: 23042704
[TBL] [Abstract][Full Text] [Related]
14. Prospective impact of panic disorder and panic-anxiety on asthma control, health service use, and quality of life in adult patients with asthma over a 4-year follow-up.
Favreau H; Bacon SL; Labrecque M; Lavoie KL
Psychosom Med; 2014 Feb; 76(2):147-55. PubMed ID: 24470131
[TBL] [Abstract][Full Text] [Related]
15. Perceived control of asthma and quality of life among adults with asthma.
Katz PP; Yelin EH; Eisner MD; Blanc PD
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):251-8. PubMed ID: 12269644
[TBL] [Abstract][Full Text] [Related]
16. Improvement in quality of life with omalizumab in patients with severe allergic asthma.
Chipps B; Buhl R; Beeh KM; Fox H; Thomas K; Reisner C
Curr Med Res Opin; 2006 Nov; 22(11):2201-8. PubMed ID: 17076981
[TBL] [Abstract][Full Text] [Related]
17. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.
Honkoop PJ; Loijmans RJ; Termeer EH; Snoeck-Stroband JB; van den Hout WB; Bakker MJ; Assendelft WJ; ter Riet G; Sterk PJ; Schermer TR; Sont JK;
J Allergy Clin Immunol; 2015 Mar; 135(3):682-8.e11. PubMed ID: 25174865
[TBL] [Abstract][Full Text] [Related]
18. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
Rubin AS; Souza-Machado A; Andradre-Lima M; Ferreira F; Honda A; Matozo TM;
J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
[TBL] [Abstract][Full Text] [Related]
20. An assessment of change in asthma control among adolescents and adults with persistent asthma in mometasone furoate/formoterol fumarate clinical trials.
Wyrwich KW; Ireland AM; Navaratnam P; Nolte H; Gates DF
J Asthma; 2011 Feb; 48(1):48-56. PubMed ID: 21039190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
